Insulin resistance medical therapy: Difference between revisions

Jump to navigation Jump to search
 
Line 4: Line 4:
==Overview==
==Overview==
==Medical Therapy==
==Medical Therapy==
The primary treatment for insulin resistance is [[exercise]] and [[weight loss]].  In some individuals, a low [[glycemic index]] or a low carbohydrate diet may also help.  Fasting might also help.  Both [[metformin]] and the [[thiazolidinedione]]s improve insulin resistance, but are only approved therapies for type 2 diabetes, not insulin resistance, per se.  By contrast, [[Growth hormone treatment|growth hormone replacement therapy]] may be associated with increased insulin resistance.<ref name=Bramnert_2003>{{cite journal | author=Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L | title=Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle | journal=THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM| year=2003| volume=88 | issue=4 | pages=1455-1463 | url=http://jcem.endojournals.org/cgi/content/full/88/4/1455 | id=PMID 12679422}}</ref>
The ''Diabetes Prevention Program'' showed that exercise and diet were nearly twice as effective as [[metformin]] at reducing the risk of progressing to type 2 diabetes.<ref name=Knowler_2002>{{cite journal | author=Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group | title=Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin | journal=[[New England Journal of Medicine]]| year=2002 | volume=346 | issue=6 | pages=393-403 | url=http://content.nejm.org/cgi/content/abstract/346/6/393 | id=PMID 11832527}}</ref>
Some types of [[Monounsaturated fat|Monounsaturated fatty acids]] and saturated fats appear to promote insulin resistance, whereas some types of [[Polyunsaturated fat|polyunsaturated fatty acids]] (omega 3) can increase insulin sensitivity.<ref name=Lovejoy_2002>{{cite journal | author=Lovejoy, JC | title=The influence of dietary fat on insulin resistance | journal=Current Diabetes Reports | year=2002 | volume=2 | issue=5 | pages= 435&ndash;440  | id=PMID 12643169}}</ref><ref name=Fukuchi_2004>{{cite journal | author=Fukuchi S | title=Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats | journal=Experimental Biology and Medicine | year=2004 | volume=229 | issue=6 | pages= 486&ndash;493 | url=http://www.ebmonline.org/cgi/content/full/229/6/486 | id=PMID 15169967}}</ref><ref name=Storlien_1996>{{cite journal | author=Storlien LH | title=Dietary fats and insulin action | journal=Diabetologica | year=1996 | volume=39 | issue=6 | pages=621&ndash;631 | id=PMID 8781757}}</ref>
There are scientific studies showing that [[chromium picolinate]] can increase insulin sensitivity, especially in type 2 diabetics, but other studies show no effect. The results are controversial.
Naturopathic approaches to insulin resistance have been advocated including supplementation of vanadium, bitter melon (momordica) and [[Gymnema sylvestre]].<ref name=Harinantenaina_2006>{{cite journal | author=Harinantenaina L | title=Momordica charantia constituents and antidiabetic screening of the isolated major compounds | journal=Chemical & Pharmaceutical Bulletin (Tokyo) | year=2006 | volume=54 | issue=7 | pages= 1017&ndash;21 | url=http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article | id=PMID 16819222}}</ref>


==References==
==References==

Latest revision as of 14:41, 19 September 2012

Insulin resistance Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Insulin Resistance from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulin resistance medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulin resistance medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulin resistance medical therapy

CDC on Insulin resistance medical therapy

Insulin resistance medical therapy in the news

Blogs on Insulin resistance medical therapy

Directions to Hospitals Treating Insulin resistance

Risk calculators and risk factors for Insulin resistance medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

The primary treatment for insulin resistance is exercise and weight loss. In some individuals, a low glycemic index or a low carbohydrate diet may also help. Fasting might also help. Both metformin and the thiazolidinediones improve insulin resistance, but are only approved therapies for type 2 diabetes, not insulin resistance, per se. By contrast, growth hormone replacement therapy may be associated with increased insulin resistance.[1]

The Diabetes Prevention Program showed that exercise and diet were nearly twice as effective as metformin at reducing the risk of progressing to type 2 diabetes.[2]

Some types of Monounsaturated fatty acids and saturated fats appear to promote insulin resistance, whereas some types of polyunsaturated fatty acids (omega 3) can increase insulin sensitivity.[3][4][5]

There are scientific studies showing that chromium picolinate can increase insulin sensitivity, especially in type 2 diabetics, but other studies show no effect. The results are controversial.

Naturopathic approaches to insulin resistance have been advocated including supplementation of vanadium, bitter melon (momordica) and Gymnema sylvestre.[6]

References

  1. Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L (2003). "Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle". THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 88 (4): 1455–1463. PMID 12679422.
  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin". New England Journal of Medicine. 346 (6): 393–403. PMID 11832527.
  3. Lovejoy, JC (2002). "The influence of dietary fat on insulin resistance". Current Diabetes Reports. 2 (5): 435&ndash, 440. PMID 12643169.
  4. Fukuchi S (2004). "Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats". Experimental Biology and Medicine. 229 (6): 486&ndash, 493. PMID 15169967.
  5. Storlien LH (1996). "Dietary fats and insulin action". Diabetologica. 39 (6): 621&ndash, 631. PMID 8781757.
  6. Harinantenaina L (2006). "Momordica charantia constituents and antidiabetic screening of the isolated major compounds". Chemical & Pharmaceutical Bulletin (Tokyo). 54 (7): 1017&ndash, 21. PMID 16819222.

Template:WH Template:WS